Usefulness of microspheres composed of gelatin with various cross-linking density.
The release rate of insulin, as a model peptide, from gelatin microspheres (GM) prepared with gelatin having various cross-linking densities in vitro was examined. The release of insulin from GM showed the burst effect, followed by a slow release phase regardless of the cross-linking density of gelatin. The total amount of insulin released in 2 weeks decreased with increasing cross-linking density of gelatin. The release rate of insulin within 6 h was well correlated with the cross-linking density of gelatin. The remaining amounts of both insulin and GM after injection of insulin incorporated in GM to mice femoral muscle tissue were also examined in vivo. Both insulin and GM rapidly disappeared from the injection site within 1 day, and thereafter slowly disappeared over 14 days. The time courses of the remaining amounts were fairly similar to each other. Furthermore, the remaining amount of insulin 1 day after administration was well correlated with the cross-linking density of gelatin. These data suggest that insulin was released from GM with the degradation of GM in mice muscular tissue and that the release rate of insulin can be controlled by modifying the cross-linking density of gelatin. In conclusion, the control of the release rate of insulin from GM can be achieved under both in vitro and in vivo conditions by gelatin through the alteration of cross-linking conditions.
Iwanaga
K
K
Department of Pharmaceutics, Osaka University of Pharmaceutical Sciences, Japan. iwanaga@gly.oups.ac.jp
Yabuta
T
T
Kakemi
M
M
Morimoto
K
K
Tabata
Y
Y
Ikada
Y
Y
D000818:Animals; D003432:Cross-Linking Reagents; D003692:Delayed-Action Preparations / Q000008:administration & dosage; D004339:Drug Compounding / Q000379:methods; D005456:Fluorescent Dyes; D005780:Gelatin; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000378:metabolism; D007273:Injections, Intramuscular; D007328:Insulin / Q000008:administration & dosage* / Q000378:metabolism; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D008863:Microspheres; D009132:Muscles / Q000187:drug effects; D012235:Rhodamines; D013997:Time Factors
D003432:Cross-Linking Reagents; D003692:Delayed-Action Preparations; D005456:Fluorescent Dyes; D007004:Hypoglycemic Agents; D007328:Insulin; D012235:Rhodamines; D005780:Gelatin; C027755:rhodamine isothiocyanate